NetEase, Inc.: Form 20-F for the period ended Dec 31, 2016
Filed with the SEC on Apr 21, 2017 and accepted by EDGAR at Apr 21, 2017, 16:17 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2016-01-01 to 2016-12-31 | $5.50bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months2016-01-01 to 2016-12-31 | $2.38bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months2016-01-01 to 2016-12-31 | $3.12bn | us-gaap:GrossProfit |
| Research and development | 12 months2016-01-01 to 2016-12-31 | $438.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2016-01-01 to 2016-12-31 | $1.82bn | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2016-01-01 to 2016-12-31 | $302.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2016-01-01 to 2016-12-31 | $1.67bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2016-01-01 to 2016-12-31 | $0.51 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2016-01-01 to 2016-12-31 | $0.51 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2016-01-01 to 2016-12-31 | 3,307,109,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2016-01-01 to 2016-12-31 | $2.23bn | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months2016-01-01 to 2016-12-31 | $163.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2016-01-01 to 2016-12-31 | $366.7m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2016-01-01 to 2016-12-31 | $172.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2016-12-31 | $783.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-12-31 | $7.19bn | us-gaap:AssetsCurrent |
| Total assets | At period end2016-12-31 | $8.36bn | us-gaap:Assets |
| Current liabilities | At period end2016-12-31 | $2.81bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-12-31 | $2.82bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2016-12-31 | $5.50bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2016-12-31 | 3,281,479,806 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001104659-17-025196. Last ingested by Listed: Nov 6, 2026, 11:02 ET. Listed shows no prices and gives no investment advice.